JP2018530349A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530349A5
JP2018530349A5 JP2018538060A JP2018538060A JP2018530349A5 JP 2018530349 A5 JP2018530349 A5 JP 2018530349A5 JP 2018538060 A JP2018538060 A JP 2018538060A JP 2018538060 A JP2018538060 A JP 2018538060A JP 2018530349 A5 JP2018530349 A5 JP 2018530349A5
Authority
JP
Japan
Prior art keywords
human
oocyte
scnt
cell
embryo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018538060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530349A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/055890 external-priority patent/WO2017062706A1/en
Publication of JP2018530349A publication Critical patent/JP2018530349A/ja
Publication of JP2018530349A5 publication Critical patent/JP2018530349A5/ja
Pending legal-status Critical Current

Links

JP2018538060A 2015-10-09 2016-10-07 ヒストンh3−リシントリメチル化の排除によりヒト体細胞核移入(scnt)の効率を増加する方法および組成物、ならびにヒトnt−escの誘導方法 Pending JP2018530349A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562239318P 2015-10-09 2015-10-09
US62/239,318 2015-10-09
US201562242050P 2015-10-15 2015-10-15
US62/242,050 2015-10-15
PCT/US2016/055890 WO2017062706A1 (en) 2015-10-09 2016-10-07 Methods and compositions to increase human somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation, and derivation of human nt-esc

Publications (2)

Publication Number Publication Date
JP2018530349A JP2018530349A (ja) 2018-10-18
JP2018530349A5 true JP2018530349A5 (enExample) 2019-11-14

Family

ID=58488507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018538060A Pending JP2018530349A (ja) 2015-10-09 2016-10-07 ヒストンh3−リシントリメチル化の排除によりヒト体細胞核移入(scnt)の効率を増加する方法および組成物、ならびにヒトnt−escの誘導方法

Country Status (6)

Country Link
US (3) US20180291400A1 (enExample)
EP (1) EP3359167A4 (enExample)
JP (1) JP2018530349A (enExample)
KR (1) KR20210143952A (enExample)
CN (1) CN109641015A (enExample)
WO (1) WO2017062706A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102473092B1 (ko) 2014-09-15 2022-12-01 칠드런'즈 메디컬 센터 코포레이션 히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
CN107299113A (zh) * 2017-06-12 2017-10-27 内蒙古大学 H3K27me3及其去甲基化酶KDM6A/B在小鼠核移植重构胚中的应用方法
CN108624621B (zh) * 2018-01-17 2019-04-12 中国科学院上海生命科学研究院 非人灵长类的体细胞克隆动物的制备方法
CN111630176A (zh) * 2018-01-23 2020-09-04 车医科学大学校产学协力团 一种包括Rad51激活剂的用于胚胎发育的组合物以及用其提高胚胎发育率的方法
WO2019147026A1 (ko) * 2018-01-23 2019-08-01 차의과학대학교 산학협력단 멜라토닌을 포함하는, 배아 발달용 조성물 및 이를 이용하여 배아 발달의 효율을 향상시키는 방법
WO2019195738A1 (en) * 2018-04-06 2019-10-10 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
EP3823663A4 (en) * 2018-07-19 2022-03-09 Children's Medical Center Corporation COMPOSITIONS AND METHODS FOR GENERATING A PHYSIOLOGICAL X-CHROMOSOME INACTIVATION
EP4386081A3 (en) * 2019-05-21 2024-10-16 President and Fellows of Harvard College Endocrine differentiation-inducing molecule
CN110607325B (zh) * 2019-09-19 2021-03-23 广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) 一种提高修正的人三原核受精卵体外培养囊胚发育率的方法
CN116113421A (zh) 2020-05-14 2023-05-12 阿莱兹精准医疗公司 使用siRNA调节PRDM2/RIZ蛋白表达的癌症治疗
US20240350492A1 (en) * 2020-07-10 2024-10-24 Ting Therapeutics Llc Methods for the Prevention and Treatment of Hearing Loss
US20230372311A1 (en) * 2020-07-21 2023-11-23 The Regents Of The University Of California Compositions and methods of treating age-related retinal dysfunction
CN112382339B (zh) * 2020-11-17 2024-08-13 中国人民解放军军事科学院军事医学研究院 一种识别合子型基因激活zga基因的方法及装置
CN114805357B (zh) * 2021-01-21 2023-12-19 四川大学 一种靶向setdb1-ttd的小分子抑制剂及其制药用途
CN113186152B (zh) * 2021-05-19 2023-05-26 南方医科大学 Dna甲基转移酶抑制剂在提高动物圆形精子注射胚胎发育效率中的应用
CN115247175B (zh) * 2021-11-25 2025-10-17 南京启真基因工程有限公司 构建setdb1基因突变的表观遗传失调模型猪核移植供体细胞的基因编辑系统及其应用
WO2025042589A1 (en) * 2023-08-18 2025-02-27 University Of Washington Compositions and methods for improving cardiac regeneration
CN118956808B (zh) * 2024-10-17 2025-01-07 天津赛萌生物技术有限公司 一种setdb1突变体及其在生物大分子制备中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483817A (zh) * 2002-09-18 2004-03-24 李建远 一种克隆无动物成分的人胚胎干细胞的方法
CN101535468A (zh) * 2005-10-21 2009-09-16 国际干细胞公司 单性生殖激活人类卵母细胞用于产生人类胚胎干细胞
US20110172107A1 (en) * 2008-04-30 2011-07-14 Fox Chase Cancer Center Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby
WO2009143421A2 (en) * 2008-05-22 2009-11-26 The Johns Hopkins University Methods for promoting fusion and reprogramming of somatic cells
US20130189780A1 (en) * 2009-12-31 2013-07-25 Fate Therapeutics, Inc. Reprogramming compositions
CN105209606A (zh) * 2013-02-15 2015-12-30 圣光医疗财团 使用体细胞核转移产生单性生殖干细胞和患者特异性人胚胎干细胞
EP2997131A4 (en) * 2013-05-13 2016-10-26 Univ Oregon Health & Science HUMAN PLURIPOTENTIAL STEM CELLS MADE BY SOMATIC CELL CORE TRANSFER
WO2014197835A2 (en) * 2013-06-06 2014-12-11 The General Hospital Corporation Methods and compositions for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2018530349A5 (enExample)
Farin et al. Development of fetuses from in vitro–produced and cloned bovine embryos
JP2017528142A5 (enExample)
CN118652837A (zh) 稳定的多能牛胚胎干细胞的高效衍生
Winger et al. Genetic reprogramming of lactate dehydrogenase, citrate synthase, and phosphofructokinase mRNA in bovine nuclear transfer embryos produced using bovine fibroblast cell nuclei
Oikawa et al. RNAi-mediated knockdown of Xist does not rescue the impaired development of female cloned mouse embryos
Hashem et al. Cell cycle analysis and interspecies nuclear transfer of in vitro cultured skin fibroblasts of the Siberian tiger (Panthera tigris Altaica)
Kwun et al. Effects of exogenous hexoses on bovine in vitro fertilized and cloned embryo development: Improved blastocyst formation after glucose replacement with fructose in a serum‐free culture medium
Al-Ghadi et al. The in vitro development of cloned sheep embryos treated with scriptaid and trichostatin (A)
Ock et al. Different activation treatments for successful development of bovine oocytes following intracytoplasmic sperm injection
AU2006243810B2 (en) A method for producing stem cells or stem cell-like cells from mammalian embryos
Jafari et al. Improved in vitro development of cloned bovine embryos using S‐adenosylhomocysteine, a non‐toxic epigenetic modifying reagent
Hamm et al. Transcriptional regulators TRIM28, SETDB1, and TP53 are aberrantly expressed in porcine embryos produced by in vitro fertilization in comparison to in vivo‐and somatic‐cell nuclear transfer‐derived embryos
KR102204413B1 (ko) Rad51 활성화제를 포함하는, 배아 발달용 조성물 및 이를 이용하여 배아 발달률을 향상시키는 방법
Terashita et al. Improving the Quality of Miniature Pig Somatic Cell Nuclear Transfer Blastocysts: Aggregation of SCNT Embryos at the Four‐cell Stage
KR20180078160A (ko) 중간엽 줄기세포의 제조방법
Eyestone et al. Nuclear transfer from somatic cells: applications in farm animal species
Morovic et al. Mouse oocytes nucleoli rescue embryonic development of porcine enucleolated oocytes
Mrowiec et al. Technical, biological and molecular aspects of somatic cell nuclear transfer–a review
Gambini et al. Embryo aggregation does not improve the development of interspecies somatic cell nuclear transfer embryos in the horse
Ma et al. TRIM28 down-regulation on methylation imprints in bovine preimplantation embryos
Niemann et al. Somatic cloning and epigenetic reprogramming in mammals
Ye et al. Caffeine and dithiothreitol delay ovine oocyte ageing
Zeng et al. Establishment and cryopreservation of liver, heart and muscle cell lines derived from the Chinese alligator (Alligator sinensis)
Fu A novel possible approach to the creation of genetically personalized human embryonic stem-like cell lines